Andy brings Harvard epidemiologist Bill Hanage back to discuss what the US can expect to see with the new Omicron subvariant BA.2. How will our bump compare to what we’re seeing in Europe? And how will people navigate it with the nationwide relaxation of vaccine and mask mandates? Plus, they revisit some of their previous conversation about the original strain of Omicron from six weeks ago to see how well their predictions held up.

Keep up with Andy on Twitter @ASlavitt and Instagram @andyslavitt.

Follow Bill @BillHanage on Twitter.

Joining Lemonada Premium is a great way to support our show and get bonus content. Subscribe today at bit.ly/lemonadapremium.

Support the show by checking out our sponsors!

Click this link for a list of current sponsors and discount codes for this show and all Lemonada shows: https://lemonadamedia.com/sponsors/
Throughout the pandemic, CVS Health has been there, bringing quality, affordable health care closer to home—so it’s never out of reach for anyone. Because at CVS Health, healthier happens together. Learn more at cvshealth.com.

Check out these resources from today’s episode:

Stay up to date with us on Twitter, Facebook, and Instagram at @LemonadaMedia.

For additional resources, information, and a transcript of the episode, visit lemonadamedia.com/show/inthebubble.

See omnystudio.com/listener for privacy information.

Volta a Catalunya Stage 1 Recap